Beer-Yaacov - Ness-Ziona Mental Health Center, Beer Yaakov, Israel.
Sackler Medical School of Tel Aviv University, Tel Aviv, Israel.
J Addict Dis. 2020 Jul-Sep;38(3):250-256. doi: 10.1080/10550887.2020.1747337. Epub 2020 Apr 16.
Non-medical use of prescription drugs for the enhancement of cognitive functioning has gained popularity in recent years, especially among young educated adults. To our knowledge, no previous study investigated this phenomenon among resident physicians. To analyze cognitive enhancement drugs use motivations and patterns among resident physicians. A survey and statistical analysis regarding the use of drugs traditionally prescribed for the treatment of Attention Deficit Hyperactivity Disorder: stimulants, amphetamines and modafinil. 1,453 residents who took their written residency exam in the summer of 2017. The response rate was 32.3%. 28.1% of responders reported past use, with 73.67% of them reporting use without a related medical diagnosis. Almost half of the users (47.1%) acquired the drug with a prescription, but without a diagnosis of a related medical disorder. The first use was predominantly during residency (54.3%), with 45% reporting it as related to the residency exam.Factors found to positively impact non-medical use include: declaring undiagnosed Attention Deficit Hyperactivity Disorder, fear of failing the exam, a belief that more than 30% of other examinees take cognitive enhancements drugs, and a learning disability diagnosis. Self-reports of being a competitive person and being a parent, were negatively correlated with non-medical use. The use of drugs that are taken traditionally for the treatment of Attention Deficit Hyperactivity Disorder is common among resident physicians, both with and without related medical indication. Interestingly, factors associated with the fear of being "left behind" increase non-medical use and not the desire to succeed.
近年来，非医疗用途的处方药物被用于提高认知功能，这种现象尤其在年轻的受过教育的成年人中流行。据我们所知，以前没有研究调查过住院医师中存在这种现象。分析住院医师使用认知增强药物的动机和模式。一项关于传统上用于治疗注意力缺陷多动障碍的药物（兴奋剂、安非他命和莫达非尼）使用情况的调查和统计分析。在 2017 年夏天参加书面住院医师考试的 1453 名住院医师。回应率为 32.3%。28.1%的应答者报告过去使用过，其中 73.67%的人在没有相关医疗诊断的情况下使用。近一半的使用者（47.1%）是凭处方获得药物的，但没有相关医疗疾病的诊断。首次使用主要是在住院期间（54.3%），45%的人报告与住院医师考试有关。发现对非医疗使用有积极影响的因素包括：宣称未被诊断出的注意力缺陷多动障碍、害怕考试不及格、相信超过 30%的其他考生服用认知增强药物，以及学习障碍诊断。自我报告为竞争型和为人父母者，与非医疗使用呈负相关。传统上用于治疗注意力缺陷多动障碍的药物在住院医师中使用较为普遍，无论是有相关医疗指征还是没有相关医疗指征。有趣的是，与害怕“落后”相关的因素会增加非医疗使用，而不是成功的愿望。
